Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

U.S. cardiovascular mortality before and during COVID-19: CDC WONDER vs GBD comparison.

American journal of epidemiology·2026
Same author

Mavacamten as an Effective Treatment for HCM With Latent Exercise-Induced Obstruction: A Case Report.

Case reports in cardiology·2026
Same author

A nationwide retrospective analysis of trends in palliative care consultation and do-not-resuscitate status in heart failure hospitalizations.

Palliative medicine·2026
Same author

Preoperative Diagnostic Assessment of Patients with Cardiovascular Risk Factors Undergoing Noncardiac Surgery: A 2025 Update.

Methodist DeBakey cardiovascular journal·2025
Same author

In HF with iron deficiency, IV ferric carboxymaltose did not reduce a composite of first HF hospitalization or CV death at a median 17 mo.

Annals of internal medicine·2025
Same author

Impact of Cardiovascular-Kidney-Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients.

Diseases (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jul 20, 2025

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K

How to select a patient for LVAD.

Kathia Cordero-Cabán1, Brian Ssembajjwe1, Jay Patel2

  • 1Internal Medicine Department, Loma Linda University Medical Center, 11234 Anderson St, Loma Linda, CA 92354 USA.

Indian Journal of Thoracic and Cardiovascular Surgery
|August 1, 2023
PubMed
Summary

Optimizing patient selection and evaluation before left ventricular assist device (LVAD) implantation is crucial for improving outcomes in advanced heart failure patients. A multidisciplinary approach ensures better results for this complex group.

Keywords:
Advanced heart failureLeft ventricular assist devicePatient selectionPsychosocial assessment

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Related Experiment Videos

Last Updated: Jul 20, 2025

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Area of Science:

  • Cardiology
  • Mechanical Circulatory Support
  • Heart Failure Management

Background:

  • Left ventricular assist device (LVAD) implantation significantly improves symptoms and survival in advanced heart failure.
  • Preoperative patient selection and optimization are critical determinants of post-LVAD outcomes.
  • Evaluating complex heart failure patients for LVAD candidacy requires a comprehensive approach.

Purpose of the Study:

  • To review the latest guidelines and considerations for evaluating advanced heart failure patients for LVAD candidacy.
  • To emphasize the importance of multidisciplinary team evaluation for LVAD selection.
  • To highlight key factors influencing successful LVAD implantation outcomes.

Main Methods:

  • Review of current literature and clinical practices for LVAD patient evaluation.
  • Discussion of criteria for patient selection and optimal implantation timing.
  • Emphasis on laboratory testing, diagnostic considerations, and psychosocial assessments.

Main Results:

  • Thorough preoperative evaluation, including psychosocial factors, is essential for successful LVAD implantation.
  • Multidisciplinary team involvement enhances the selection and optimization process.
  • Careful patient selection and timing can mitigate risks and improve post-LVAD recovery.

Conclusions:

  • Optimal preoperative assessment is paramount for improving outcomes in patients undergoing LVAD implantation.
  • A comprehensive, multidisciplinary evaluation strategy is recommended for LVAD candidacy.
  • This approach aims to maximize the benefits of LVAD therapy for advanced heart failure.